Emergent BioSolutions Inc. (EBS)

Emergent BioSolutions Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	139.5	-190.6	-760.5	-211.6	219.5	305.8
Depreciation & Amortization	101.3	108.8	125.1	130.6	123.8	114.5
Other Amortization	0.2	7.4	21.3	4.1	4.1	3.5
Loss (Gain) From Sale of Assets	-45.9	-3.5	-53.1	3.6	-	-
Asset Writedown & Restructuring Costs	-	27.2	524.9	19.4	41.7	29
Stock-Based Compensation	12.7	18	23.1	45.1	42.4	51.8
Other Operating Activities	3.9	2.7	-16.8	-23.2	33.7	22.8
Change in Accounts Receivable	50.4	-24.4	-21.6	118.1	-16.2	27.5
Change in Inventory	-33.9	-24.5	0.6	-57.1	-66.6	-66.9
Change in Accounts Payable	-49	-33	10.6	-14	-1.6	28.3
Change in Unearned Revenue	-0.9	-20.3	5.9	9.6	-31.8	11.2
Change in Income Taxes	5.6	23.3	-16.2	28.7	-31.3	6
Change in Other Net Operating Assets	-14.9	167.6	-49.6	-87.4	2.5	3.4
Operating Cash Flow	169	58.7	-206.3	-34.1	320.2	536.9
Operating Cash Flow Growth	119.48%	-	-	-	-40.36%	185.59%
Capital Expenditures	-14	-22.9	-51.6	-115.8	-224.1	-141.9
Sale of Property, Plant & Equipment	96.1	7.9	-	-	-	-
Divestitures	110.2	110.2	270.2	-	-	-
Sale (Purchase) of Intangibles	30	30	-6.3	-243.7	-	-10
Other Investing Activities	-5	-	-	-21.8	-	-
Investing Cash Flow	217.3	125.2	212.3	-381.3	-224.1	-151.9
Long-Term Debt Issued	-	284	20	598	-	450
Long-Term Debt Repaid	-	-482.4	-563.4	-33.8	-35.9	-387.1
Total Debt Repaid	-413	-482.4	-563.4	-33.8	-35.9	-387.1
Net Debt Issued (Repaid)	-194	-198.4	-543.4	564.2	-35.9	62.9
Issuance of Common Stock	10.9	10.8	10.2	5	15.9	31.6
Repurchase of Common Stock	-8.2	-1.2	-2.5	-88	-119.8	-13.8
Other Financing Activities	4.7	-1.2	-	-	-1.2	-11.2
Financing Cash Flow	-186.6	-190	-535.7	481.2	-141	69.5
Foreign Exchange Rate Adjustments	0.3	-	-1.2	0.5	-0.3	-1
Net Cash Flow	200	-6.1	-530.9	66.3	-45.2	453.5
Free Cash Flow	155	35.8	-257.9	-149.9	96.1	395
Free Cash Flow Growth	312.23%	-	-	-	-75.67%	290.70%
Free Cash Flow Margin	18.20%	3.43%	-24.58%	-13.41%	5.42%	25.04%
Free Cash Flow Per Share	2.81	0.68	-5.04	-2.99	1.78	7.34
Cash Interest Paid	52.8	64	68.3	33	30.4	21
Cash Income Tax Paid	17.2	26.5	52.8	6.2	71.6	109.3
Levered Free Cash Flow	227.64	58.5	-88.6	-203.13	39.19	393.94
Unlevered Free Cash Flow	260.25	95.48	-54.96	-183.91	56.65	410
Change in Working Capital	-42.7	88.7	-70.3	-2.1	-145	9.5

Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q